Takeda establishes new drug discovery subsidiary
Also transfers part of its pharmaceutical sciences businesses to Bushu
Read More
Author: Dominic Tyer
Triple trial boost for Lilly’s migraine drug
CGRP treatment galcanezumab looks to be course for regulatory submissions
Read More
NHS cyber attack – fallout continues
Cancellations and slower health services after 48 NHS Trusts hit by ransomware
Read More
NHS Confederation calls on government for health funding plan
The body presents case for 10 ‘asks’ before the snap election
Read More
Pfizer strikes gene therapy deal with Sangamo
Says one of the candidates included has best-in-class potential
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
